Clinical trial
Feasibility of a New Model for Exercise Prescription Combined With Behavior Modification in Cystic Fibrosis
NCT04075864 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of a New Model for Exercise Prescription Combined With Behavior Modification in Cystic Fibrosis
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 1, 2020
- Completion date
- December 10, 2025
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.